Evidence map›Paper›PMID 41440076›Full record

ReviewBrain sciences2025

A Review of Therapeutic Approaches for Autism Spectrum Disorder.

Yang Hai, Saihan Bai, Huiting Qiao, Deyu Li, Daifa Wang, Meiyun Xia

Abstract readReview
In one paragraph

Review in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yang HaiMedical Engineering & Engineering Medicine Innovation Center, Hangzhou International Innovation Institute, Beihang University, Hangzhou 311115, China.ORCID 0009-0009-5984-4236
Saihan BaiMedical Engineering & Engineering Medicine Innovation Center, Hangzhou International Innovation Institute, Beihang University, Hangzhou 311115, China.
Huiting QiaoSchool of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China.
Deyu LiSchool of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China.
Daifa WangSchool of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China.
Meiyun XiaMedical Engineering & Engineering Medicine Innovation Center, Hangzhou International Innovation Institute, Beihang University, Hangzhou 311115, China.

Funding

the China Disabled Persons' Federation special topic CDPF2023KF00001the National Natural Science Foundation of China 8246140544the Research Funding of Hangzhou International Innovation Institute of Beihang University 2024KQ098
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a highly heterogeneous neurodevelopmental disorder. Significant progress has been made in the intervention and treatment of ASD. This review systematically summarizes five major categories of mainstream ASD treatment approaches. This article outlines the theoretical basis and therapeutic effects of each intervention method, discusses their advantages and limitations, and analyzes and forecasts future development directions. Due to the lack of specific treatment methods, ASD treatment primarily relies on behavioral interventions, supplemented by symptomatic pharmacological treatments. Behavioral interventions can significantly improve children's self-care abilities and quality of life while also promoting social skills and communication, and reducing disability and comorbidity rates. ASD intervention methods should primarily focus on those proven effective through evidence-based practice, adhering to individualized, multidimensional, and multidisciplinary approaches, thereby promoting the development and establishment of efficient and personalized intervention strategies.

Indexed as

autism spectrum disorderbehavioral interventioncomplementary and alternative medicineearly interventionmulti-modal therapyneuro-modulation techniquespharmacological treatmentprecision medicinetraditional Chinese medicine

Identifiers

PMID41440076
PMCPMC12730961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.